• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Addressing Failed Patient Follow-Ups During the Pandemic

Video

COVID-19 is an additional factor in patients shying away from follow-up exams. Nuance Communication’s Sander Kloet shares his perspectives from SIIM on addressing this issue.

One of the most widespread impacts of the COVID-19 pandemic has been the delayed study. For many patients, their screening or diagnostic studies have been put on hold for the foreseeable future. But, the postponement is more than a simple delay – it is a compounding factor that is starting to make an already existing problem worse.

It is no secret in the industry that patients who fail to arrive for follow-up care are a pervasive pain point for practices. Add in the delay, the risk, and the fear associated with the pandemic, and it is recipe for an even deeper drop in imaging volume.

Related Content: Contacting Patients About Abnormal Findings Isn’t Enough to Prompt Follow-Up

To help practices address this issue – and potentially side-step it – Diagnostic Imaging spoke with Sander Kloet, senior director of product management, diagnostics, for Nuance Communications about his session during Society for Imaging Informatics in Medicine 2020 Virtual Meeting. Here, he shares his insights on the frequency of the problem during the pandemic, strategies facilities can use to reduce the impact of failed follow-ups, and proactive tactics practices can implement.

Recent Videos
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2025 MJH Life Sciences

All rights reserved.